Signaling through Galpha12/13 and RGS-RhoGEFs

  • Nicole Hajicek
  • Barry Kreutz
  • Tohru Kozasa


The transforming heterotrimeric G proteins Gα12 and Gα13 have been implicated in the regulation of various cellular processes, such as gene transcription and rearrangement of the actin-based cytoskeleton. Many of these functions are dependent on the activation of the monomeric GTPase RhoA. The RGS-RhoGEFs, a distinct family of guanine nucleotide exchange factors, which contain RGS-like domains in their N-termini, serve as direct links between Gα12/13 and RhoA. The focus of this chapter is on the molecular mechanisms that underlie and regulate signaling from Gα12/13 to RhoA via the RGS-RhoGEFs. The physiological significance of this signaling pathway is also discussed.


Acute Myeloid Leukemia Guanine Nucleotide Exchange Factor Neurite Retraction Guanine Nucleotide Exchange Activity Nucleotide Exchange Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We would like to apologize to our colleagues whose contributions to this field were inadvertently omitted or could not be properly acknowledged due to space limitations.


  1. Aasheim, H. C., Pedeutour, F. and Smeland, E. B. 1997. Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues. Oncogene 14: 1747–1752.CrossRefPubMedGoogle Scholar
  2. Aurandt, J. et al. 2002. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci U S A 99: 12085–12090.CrossRefGoogle Scholar
  3. Avraham, H. and Weinberg, R. A. 1989. Characterization and expression of the human rhoH12 gene product. Mol Cell Biol 9: 2058–2066.PubMedGoogle Scholar
  4. Banerjee, J. and Wedegaertner, P. B. 2004. Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton. Mol Biol Cell 15: 1760–1775.CrossRefPubMedGoogle Scholar
  5. Barrett, K., Leptin, M. and Settleman, J. 1997. The Rho GTPase and a putative RhoGEF mediate a signaling pathway for the cell shape changes in Drosophila gastrulation. Cell 91: 905–915.CrossRefPubMedGoogle Scholar
  6. Bhattacharyya, R. and Wedegaertner, P. B. 2000. Galpha 13 requires palmitoylation for plasma membrane localization, Rho-dependent signaling, and promotion of p115-RhoGEF membrane binding. J Biol Chem 275: 14992–14999.CrossRefPubMedGoogle Scholar
  7. Bhattacharyya, R. and Wedegaertner, P. B. 2003a. Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF. Biochem J 371: 709–720.CrossRefGoogle Scholar
  8. Bhattacharyya, R. and Wedegaertner, P. B. 2003b. Mutation of an N-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment. FEBS Lett 540: 211–216.CrossRefGoogle Scholar
  9. Boettner, B. and Van Aelst, L. 2002. The role of Rho GTPases in disease development. Gene 286: 155–174.CrossRefPubMedGoogle Scholar
  10. Booden, M. A., Siderovski, D. P. and Der, C. J. 2002. Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA. Mol Cell Biol 22: 4053–4061.CrossRefPubMedGoogle Scholar
  11. Bos, J. L. 1988. The ras gene family and human carcinogenesis. Mutat Res 195: 255–271.PubMedGoogle Scholar
  12. Bourguignon, L. Y. et al. 2006. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2 + signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 281: 14026–14040.CrossRefPubMedGoogle Scholar
  13. Chen, Z. et al. 2005. Structure of the p115RhoGEF rgRGS domain-Galpha13/i1 chimera complex suggests convergent evolution of a GTPase activator. Nat Struct Mol Biol 12: 191–197.CrossRefPubMedGoogle Scholar
  14. Chen, Z. et al. 2003. Mapping the Galpha13 binding interface of the rgRGS domain of p115RhoGEF. J Biol Chem 278: 9912–9919.CrossRefPubMedGoogle Scholar
  15. Chen, Z. et al. 2001. Structure of the rgRGS domain of p115RhoGEF. Nat Struct Biol 8: 805–809.CrossRefPubMedGoogle Scholar
  16. Chikumi, H. et al. 2004. Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential. Oncogene 23: 233–240.CrossRefPubMedGoogle Scholar
  17. Chikumi, H., Fukuhara, S. and Gutkind, J. S. 2002. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase. J Biol Chem 277: 12463–12473.CrossRefPubMedGoogle Scholar
  18. Clark, E. A. et al. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532–535.CrossRefPubMedGoogle Scholar
  19. Derewenda, U. et al. 2004. The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle. Structure 12: 1955–1965.CrossRefPubMedGoogle Scholar
  20. Doupnik, C. A. et al. 1997. RGS proteins reconstitute the rapid gating kinetics of gbetagamma-activated inwardly rectifying K + channels. Proc Natl Acad Sci U S A 94: 10461–10466.CrossRefPubMedGoogle Scholar
  21. Eisenhaure, T. M. et al. 2003. The Rho guanine nucleotide exchange factor Lsc homo-oligomerizes and is negatively regulated through domains in its carboxyl terminus that are absent in novel splenic isoforms. J Biol Chem 278: 30975–30984.CrossRefPubMedGoogle Scholar
  22. Francis, S. A. et al. 2006. Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils. Blood 107: 1627–1635.CrossRefPubMedGoogle Scholar
  23. Fritz, G. et al. 2002. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87: 635–644.CrossRefPubMedGoogle Scholar
  24. Fritz, G., Just, I. and Kaina, B. 1999. Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682–687.CrossRefPubMedGoogle Scholar
  25. Fukuhara, S., Chikumi, H. and Gutkind, J. S. 2000. Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho. FEBS Lett 485: 183–188.CrossRefPubMedGoogle Scholar
  26. Fukuhara, S., Chikumi, H. and Gutkind, J. S. 2001. RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 20: 1661–1668.CrossRefPubMedGoogle Scholar
  27. Fukuhara, S. et al. 1999. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274: 5868–5879.CrossRefPubMedGoogle Scholar
  28. Girkontaite, I. et al. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2: 855–862.CrossRefPubMedGoogle Scholar
  29. Gohla, A., Harhammer, R. and Schultz, G. 1998. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J Biol Chem 273: 4653–4659.CrossRefPubMedGoogle Scholar
  30. Grabocka, E. and Wedegaertner, P. B. 2005. Functional consequences of G alpha 13 mutations that disrupt interaction with p115RhoGEF. Oncogene 24: 2155–2165.CrossRefPubMedGoogle Scholar
  31. Grabocka, E. and Wedegaertner, P. B. 2007. Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated rho Guanine-nucleotide exchange factor. Mol Pharmacol 72: 993–1002.CrossRefPubMedGoogle Scholar
  32. Gu, J. et al. 2006. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer 106: 2716–2724.PubMedGoogle Scholar
  33. Gu, J. L. et al. 2002. Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc Natl Acad Sci U S A 99: 9352–9357.CrossRefPubMedGoogle Scholar
  34. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509–514.CrossRefPubMedGoogle Scholar
  35. Hart, M. J. et al. 1998. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280: 2112–2114.CrossRefPubMedGoogle Scholar
  36. Hart, M. J. et al. 1996. Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem 271: 25452–25458.CrossRefPubMedGoogle Scholar
  37. Hiley, E., McMullan, R. and Nurrish, S. J. 2006. The Galpha12-RGS RhoGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans. Embo J 25: 5884–5895.CrossRefPubMedGoogle Scholar
  38. Hirotani, M. et al. 2002. Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. Biochem Biophys Res Commun 297: 32–37.CrossRefPubMedGoogle Scholar
  39. Holinstat, M. et al. 2003. Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem 278: 28793–28798.CrossRefPubMedGoogle Scholar
  40. Jackson, M. et al. 2001. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature 410: 89–93.CrossRefPubMedGoogle Scholar
  41. Katoh, H. et al. 1998. Constitutively active Galpha12, Galpha13, and Galphaq induce Rho-dependent neurite retraction through different signaling pathways. J Biol Chem 273: 28700–28707.CrossRefPubMedGoogle Scholar
  42. Khosravi-Far, R. et al. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15: 6443–6453.PubMedGoogle Scholar
  43. Kitzing, T. M. et al. 2007. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev 21: 1478–1483.CrossRefPubMedGoogle Scholar
  44. Kourlas, P. J. et al. 2000. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A 97: 2145–2150.CrossRefPubMedGoogle Scholar
  45. Kozasa, T. et al. 1998. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280: 2109–2111.CrossRefPubMedGoogle Scholar
  46. Kranenburg, O. et al. 1999. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Mol Biol Cell 10: 1851–1857.PubMedGoogle Scholar
  47. Kreutz, B. et al. 2007. Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing RhoGEFs. Cell Signal 19: 1681–1689.CrossRefPubMedGoogle Scholar
  48. Kreutz, B. et al. 2006. A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins. Biochemistry 45: 167–174.CrossRefPubMedGoogle Scholar
  49. Kristelly, R., Gao, G. and Tesmer, J. J. 2004. Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor. J Biol Chem 279: 47352–47362.CrossRefPubMedGoogle Scholar
  50. Longenecker, K. L. et al. 2001. Structure of the RGS-like domain from PDZ-RhoGEF: linking heterotrimeric g protein-coupled signaling to Rho GTPases. Structure 9: 559–569.CrossRefPubMedGoogle Scholar
  51. Majumdar, M. et al. 1999. A rho exchange factor mediates thrombin and Galpha(12)-induced cytoskeletal responses. J Biol Chem 274: 26815–26821.CrossRefPubMedGoogle Scholar
  52. Mao, J. et al. 1998a. Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13. Embo J 17: 5638–5646.CrossRefGoogle Scholar
  53. Mao, J. et al. 1998b. Guanine nucleotide exchange factor GEF115 specifically mediates activation of Rho and serum response factor by the G protein alpha subunit Galpha13. Proc Natl Acad Sci U S A 95: 12973–12976.CrossRefGoogle Scholar
  54. McMullan, R. et al. 2006. Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans. Genes Dev 20: 65–76.CrossRefPubMedGoogle Scholar
  55. Moers, A. et al. 2003. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9: 1418–1422.CrossRefPubMedGoogle Scholar
  56. Nakamura, S. et al. 2004. Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated RhoGEF. Mol Pharmacol 66: 1029–1034.CrossRefPubMedGoogle Scholar
  57. Offermanns, S. et al. 1994. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci U S A 91: 504–508.CrossRefPubMedGoogle Scholar
  58. Offermanns, S. et al. 1997. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275: 533–536.CrossRefPubMedGoogle Scholar
  59. Oleksy, A. et al. 2006. The molecular basis of RhoA specificity in the guanine nucleotide exchange factor PDZ-RhoGEF. J Biol Chem 281: 32891–32897.CrossRefPubMedGoogle Scholar
  60. Parks, S. and Wieschaus, E. 1991. The Drosophila gastrulation gene concertina encodes a G alpha-like protein. Cell 64: 447–458.CrossRefPubMedGoogle Scholar
  61. Perrot, V., Vazquez-Prado, J. and Gutkind, J. S. 2002. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 277: 43115–43120.CrossRefPubMedGoogle Scholar
  62. Qiu, R. G. et al. 1995. A role for Rho in Ras transformation. Proc Natl Acad Sci U S A 92: 11781–11785.CrossRefPubMedGoogle Scholar
  63. Radhika, V. and Dhanasekaran, N. 2001. Transforming G proteins. Oncogene 20: 1607–1614.CrossRefPubMedGoogle Scholar
  64. Reuther, G. W. et al. 2001. Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J Biol Chem 276: 27145–27151.CrossRefPubMedGoogle Scholar
  65. Rossman, K. L., Der, C. J. and Sondek, J. 2005. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167–180.CrossRefPubMedGoogle Scholar
  66. Rubtsov, A. et al. 2005. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 23: 527–538.CrossRefPubMedGoogle Scholar
  67. Rujkijyanont, P. et al. 2007. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome. Br J Haematol 137: 537–544.CrossRefPubMedGoogle Scholar
  68. Rumenapp, U. et al. 1999. Rho-specific binding and guanine nucleotide exchange catalysis by KIAA0380, a dbl family member. FEBS Lett 459: 313–318.CrossRefPubMedGoogle Scholar
  69. Ruppel, K. M. et al. 2005. Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A 102: 8281–8286.CrossRefPubMedGoogle Scholar
  70. Sahai, E. and Marshall, C. J. 2002. RHO-GTPases and cancer. Nat Rev Cancer 2: 133–142.CrossRefPubMedGoogle Scholar
  71. Sahai, E., Olson, M. F. and Marshall, C. J. 2001. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. Embo J 20: 755–766.CrossRefPubMedGoogle Scholar
  72. Saitoh, O. et al. 1997. RGS8 accelerates G-protein-mediated modulation of K + currents. Nature 390: 525–529.CrossRefPubMedGoogle Scholar
  73. Singer, W. D., Miller, R. T. and Sternweis, P. C. 1994. Purification and characterization of the alpha subunit of G13. J Biol Chem 269: 19796–19802.PubMedGoogle Scholar
  74. Sjoblom, T. et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314: 268–274.CrossRefPubMedGoogle Scholar
  75. Slep, K. C. et al. 2001. Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 A. Nature 409: 1071–1077.CrossRefPubMedGoogle Scholar
  76. Suzuki, N. et al. 2003. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci U S A 100: 733–738.CrossRefPubMedGoogle Scholar
  77. Suzuki, N. et al. 2009. Activation of leukemia-associated RhoGEF by Ga13 with significant rearrangements in the interface. J Biol Chem 284: 5000–5009.Google Scholar
  78. Swiercz, J. M. et al. 2002. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35: 51–63.CrossRefPubMedGoogle Scholar
  79. Taya, S. et al. 2001. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol 155: 809–820.CrossRefPubMedGoogle Scholar
  80. Tesmer, J. J. et al. 1997. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science 278: 1907–1916.CrossRefPubMedGoogle Scholar
  81. Tesmer, V. M. et al. 2005. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 310: 1686–1690.CrossRefPubMedGoogle Scholar
  82. Togashi, H. et al. 2000. Functions of a rho-specific guanine nucleotide exchange factor in neurite retraction. Possible role of a proline-rich motif of KIAA0380 in localization. J Biol Chem 275: 29570–29578.CrossRefPubMedGoogle Scholar
  83. Van Aelst, L. and D’Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev 11: 2295–2322.CrossRefPubMedGoogle Scholar
  84. Vazquez-Prado, J. et al. 2004. Chimeric G alpha i2/G alpha 13 proteins reveal the structural requirements for the binding and activation of the RGS-like (RGL)-containing Rho guanine nucleotide exchange factors (GEFs) by G alpha 13. J Biol Chem 279: 54283–54290.CrossRefPubMedGoogle Scholar
  85. Wells, C. D. et al. 2001. Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor. J Biol Chem 276: 28897–28905.CrossRefPubMedGoogle Scholar
  86. Wells, C. D. et al. 2002. Mechanisms for reversible regulation between G13 and Rho exchange factors. J Biol Chem 277: 1174–1181.CrossRefPubMedGoogle Scholar
  87. Whitehead, I. P. et al. 1996. Expression cloning of lsc, a novel oncogene with structural similarities to the Dbl family of guanine nucleotide exchange factors. J Biol Chem 271: 18643–18650.CrossRefPubMedGoogle Scholar
  88. Wirth, A. et al. 2008. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 14: 64–68.CrossRefPubMedGoogle Scholar
  89. Wong, K., Van Keymeulen, A. and Bourne, H. R. 2007. PDZRhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophil-like cells. J Cell Biol 179: 1141–1148.CrossRefPubMedGoogle Scholar
  90. Xu, N. et al. 1993. A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proc Natl Acad Sci U S A 90: 6741–6745.CrossRefPubMedGoogle Scholar
  91. Xu, N., Voyno-Yasenetskaya, T. and Gutkind, J. S. 1994. Potent transforming activity of the G13 alpha subunit defines a novel family of oncogenes. Biochem Biophys Res Commun 201: 603–609.CrossRefPubMedGoogle Scholar
  92. Yamada, T. et al. 2005. Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs). J Biol Chem 280: 19358–19363.CrossRefPubMedGoogle Scholar
  93. Yau, D. M. et al. 2003. Identification and molecular characterization of the G alpha12-Rho guanine nucleotide exchange factor pathway in Caenorhabditis elegans. Proc Natl Acad Sci U S A 100: 14748–14753.CrossRefPubMedGoogle Scholar
  94. Zhang, H. et al. 1999. Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. Curr Biol 9: 1271–1274.CrossRefPubMedGoogle Scholar
  95. Zhong, H. et al. 2003. A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protein-mediated kinetic scaffolding. J Biol Chem 278: 7278–7284.CrossRefPubMedGoogle Scholar
  96. Zinovyeva, M. et al. 2004. Molecular cloning, sequence and expression pattern analysis of the mouse orthologue of the leukemia-associated guanine nucleotide exchange factor. Gene 337: 181–188.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of PharmacologyCollege of Medicine, University of Illinois at ChicagoChicagoUSA

Personalised recommendations